Thomas Shupe

Wake Forest University — United States

Medicine · Health Sciences

26h-index5.6kcitations59works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(21), 3D Printing in Biomedical Research(20), Tissue Engineering and Regenerative Medicine(15), Pluripotent Stem Cells Research(9), Pancreatic function and diabetes(9)

Publications58 total

A Multiaxial Bioreactor Integrated with an Environmental Monitoring System for Tissue‐Engineered Skin Grafts
Advanced Healthcare Materials·2026Open Access
A Human Airway-on-a-Chip Microphysiological System for Modeling Chlorine Gas Toxicity
Toxicological Sciences·2025Open Access
Silica-Based Fiber Universal Combat Matrix Reduces Inflammation, Supporting Cellular Migration and Extracellular Matrix Remodeling in Porcine Full-Thickness Burns
Military Medicine·2025
Corrigendum to ‘Bioprinting 3D microfibrous scaffolds for engineering cardiac tissues and heart-on-a-chip’ [Biomaterials Volume 110, (2016) Pages 45–59]
Biomaterials·2025
Development of a multifunctional uniaxial bioreactor with real-time monitoring of culture conditions and tissue health
Bio-Design and Manufacturing·2025· 3 cited
In Vitro Generation of Haploid Germ Cells from Human XY and XXY Immature Testes in a 3D Organoid System
Bioengineering·2024· 5 citedOpen Access
3D Bioprinted Liver-on-a-Chip for Drug Cytotoxicity Screening
Tissue Engineering Part A·2023· 13 citedOpen Access
Bioreactor design and validation for manufacturing strategies in tissue engineering
Bio-Design and Manufacturing·2021· 61 citedOpen Access
Drug compound screening in single and integrated multi-organoid body-on-a-chip systems
Biofabrication·2020· 245 cited
Body-on-a-chip: three-dimensional engineered tissue models
Elsevier eBooks·2020· 1 cited
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
The FASEB Journal·2019· 33 citedOpen Access
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosis
Endocrine Abstracts·2019· 1 cited
Body-on-a-Chip for Pharmacology and Toxicology
2019
SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis
Journal of the Endocrine Society·2019Open Access
Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction
Stem Cell Research & Therapy·2018· 73 citedOpen Access
Body-on-a-Chip: Regenerative Medicine for Personalized Medicine
Elsevier eBooks·2018· 11 cited
An Industry-Driven Roadmap for Manufacturing in Regenerative Medicine
Stem Cells Translational Medicine·2018· 41 citedOpen Access
Environmental Toxin Screening Using Human-Derived 3D Bioengineered Liver and Cardiac Organoids
Frontiers in Public Health·2018· 103 citedOpen Access
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Scientific Reports·2017· 578 citedOpen Access
Optical Tracking and Digital Quantification of Beating Behavior in Bioengineered Human Cardiac Organoids
Biosensors·2017· 46 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Anthony Atala(22), Bryon E. Petersen(22), Colin E. Bishop(13), Shay Söker(13), Aleksander Skardal(12), Mahesh Devarasetty(8), James J. Yoo(6), Antonio Gasbarrini(6), Seh‐Hoon Oh(6), Steven D. Forsythe(5), A.C. Piscaglia(5), Yu Shrike Zhang(4), Julio Aleman(4), Mehmet R. Dokmeci(4), Ali Khademhosseini(4), Cynthia Zimmerman(4), Sean V. Murphy(3), Adam R. Hall(3), Sang Jin Lee(3), Houda Darwiche(3)